Impact of corticosteroids in hospitalised COVID-19 patients

BACKGROUND: Corticosteroids are a potential therapeutic agent for patients with COVID-19 pneumonia. The RECOVERY (Randomised Trials in COVID-19 Therapy) trial provided data on the mortality benefits of corticosteroids. The study aimed to determine the association between corticosteroid use on mortal...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Kam Sing, Narasimhan, Bharat, Difabrizio, Larry, Rogers, Linda, Bose, Sonali, Li, Li, Chen, Roger, Sheehan, Jacqueline, El-Halabi, Maan Ajwad, Sarosky, Kimberly, Wang, Zichen, Eisenberg, Elliot, Powell, Charles, Steiger, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Respiratory Infection
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023732/
https://www.ncbi.nlm.nih.gov/pubmed/33811098
http://dx.doi.org/10.1136/bmjresp-2020-000766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023732/
https://www.ncbi.nlm.nih.gov/pubmed/33811098
http://dx.doi.org/10.1136/bmjresp-2020-000766

Ejemplares similares